Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 24% ± 6% | |
glutamatergic neuron | 4 studies | 39% ± 18% | |
astrocyte | 3 studies | 21% ± 3% | |
oligodendrocyte | 3 studies | 25% ± 5% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 35% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5175.83 | 245 / 245 | 100% | 10.02 | 502 / 502 |
esophagus | 100% | 4019.73 | 1442 / 1445 | 100% | 8.03 | 183 / 183 |
breast | 100% | 3718.92 | 459 / 459 | 100% | 8.81 | 1115 / 1118 |
skin | 100% | 3300.59 | 1807 / 1809 | 100% | 12.40 | 471 / 472 |
intestine | 100% | 5995.04 | 966 / 966 | 100% | 6.72 | 525 / 527 |
lung | 100% | 5082.28 | 578 / 578 | 100% | 8.75 | 1150 / 1155 |
thymus | 100% | 4847.99 | 653 / 653 | 100% | 12.74 | 602 / 605 |
uterus | 100% | 6523.50 | 170 / 170 | 99% | 9.18 | 456 / 459 |
kidney | 100% | 2579.55 | 89 / 89 | 99% | 9.96 | 892 / 901 |
bladder | 100% | 4938.05 | 21 / 21 | 99% | 7.65 | 498 / 504 |
adrenal gland | 100% | 3305.32 | 258 / 258 | 99% | 9.01 | 227 / 230 |
stomach | 100% | 3280.44 | 358 / 359 | 99% | 6.91 | 283 / 286 |
liver | 100% | 2749.88 | 226 / 226 | 98% | 6.86 | 397 / 406 |
brain | 98% | 4542.10 | 2585 / 2642 | 100% | 13.91 | 704 / 705 |
ovary | 100% | 6116.51 | 180 / 180 | 97% | 5.73 | 419 / 430 |
pancreas | 95% | 1599.13 | 312 / 328 | 99% | 8.84 | 177 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.18 | 29 / 29 |
spleen | 100% | 5484.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.35 | 45 / 45 |
adipose | 100% | 3982.94 | 1203 / 1204 | 0% | 0 | 0 / 0 |
muscle | 100% | 3978.58 | 802 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 3786.56 | 1327 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 10.69 | 78 / 80 |
peripheral blood | 97% | 2474.91 | 905 / 929 | 0% | 0 | 0 / 0 |
heart | 97% | 3011.24 | 836 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0050673 | Biological process | epithelial cell proliferation |
GO_0097009 | Biological process | energy homeostasis |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0035024 | Biological process | negative regulation of Rho protein signal transduction |
GO_0007043 | Biological process | cell-cell junction assembly |
GO_2000973 | Biological process | regulation of pro-B cell differentiation |
GO_0030097 | Biological process | hemopoiesis |
GO_0001701 | Biological process | in utero embryonic development |
GO_0046578 | Biological process | regulation of Ras protein signal transduction |
GO_0031929 | Biological process | TOR signaling |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
GO_1901874 | Biological process | negative regulation of post-translational protein modification |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0072111 | Biological process | cell proliferation involved in kidney development |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0009267 | Biological process | cellular response to starvation |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0051898 | Biological process | negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0045820 | Biological process | negative regulation of glycolytic process |
GO_1905672 | Biological process | negative regulation of lysosome organization |
GO_0097193 | Biological process | intrinsic apoptotic signaling pathway |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0032418 | Biological process | lysosome localization |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_1901723 | Biological process | negative regulation of cell proliferation involved in kidney development |
GO_1903444 | Biological process | negative regulation of brown fat cell differentiation |
GO_1904263 | Biological process | positive regulation of TORC1 signaling |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0032006 | Biological process | regulation of TOR signaling |
GO_0032008 | Biological process | positive regulation of TOR signaling |
GO_0120163 | Biological process | negative regulation of cold-induced thermogenesis |
GO_0030496 | Cellular component | midbody |
GO_0005886 | Cellular component | plasma membrane |
GO_0072686 | Cellular component | mitotic spindle |
GO_0005813 | Cellular component | centrosome |
GO_0005764 | Cellular component | lysosome |
GO_0044291 | Cellular component | cell-cell contact zone |
GO_0005929 | Cellular component | cilium |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_1990877 | Cellular component | FNIP-folliculin RagC/D GAP |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0019899 | Molecular function | enzyme binding |
GO_0004857 | Molecular function | enzyme inhibitor activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | FLCN |
Protein name | Folliculin isoform 1 (Folliculin, isoform CRA_a) Folliculin isoform 3 Folliculin (BHD skin lesion fibrofolliculoma protein) (Birt-Hogg-Dube syndrome protein) Folliculin |
Synonyms | hCG_1775424 BHD |
Description | FUNCTION: Multi-functional protein, involved in both the cellular response to amino acid availability and in the regulation of glycolysis . GTPase-activating protein that plays a key role in the cellular response to amino acid availability through regulation of the non-canonical mTORC1 signaling cascade controlling the MiT/TFE factors TFEB and TFE3 . Activates mTORC1 by acting as a GTPase-activating protein: specifically stimulates GTP hydrolysis by RagC/RRAGC or RagD/RRAGD, promoting the conversion to the GDP-bound state of RagC/RRAGC or RagD/RRAGD, and thereby activating the kinase activity of mTORC1 . The GTPase-activating activity is inhibited during starvation and activated in presence of nutrients . Acts as a key component for non-canonical mTORC1-dependent control of the MiT/TFE factors TFEB and TFE3, while it is not involved in mTORC1-dependent phosphorylation of canonical RPS6KB1/S6K1 and EIF4EBP1/4E-BP1 . In low-amino acid conditions, the lysosomal folliculin complex (LFC) is formed on the membrane of lysosomes, which inhibits the GTPase-activating activity of FLCN, inactivates mTORC1 and maximizes nuclear translocation of TFEB and TFE3 . Upon amino acid restimulation, RagA/RRAGA (or RagB/RRAGB) nucleotide exchange promotes disassembly of the LFC complex and liberates the GTPase-activating activity of FLCN, leading to activation of mTORC1 and subsequent cytoplasmic retention of TFEB and TFE3 . Indirectly acts as a positive regulator of Wnt signaling by promoting mTOR-dependent cytoplasmic retention of MiT/TFE factor TFE3 . Required for the exit of hematopoietic stem cell from pluripotency by promoting mTOR-dependent cytoplasmic retention of TFE3, thereby increasing Wnt signaling . Acts as an inhibitor of browning of adipose tissue by regulating mTOR-dependent cytoplasmic retention of TFE3 (By similarity). Involved in the control of embryonic stem cells differentiation; together with LAMTOR1 it is necessary to recruit and activate RagC/RRAGC and RagD/RRAGD at the lysosomes, and to induce exit of embryonic stem cells from pluripotency via non-canonical, mTOR-independent TFE3 inactivation (By similarity). In response to flow stress, regulates STK11/LKB1 accumulation and mTORC1 activation through primary cilia: may act by recruiting STK11/LKB1 to primary cilia for activation of AMPK resided at basal bodies, causing mTORC1 down-regulation . Together with FNIP1 and/or FNIP2, regulates autophagy: following phosphorylation by ULK1, interacts with GABARAP and promotes autophagy . Required for starvation-induced perinuclear clustering of lysosomes by promoting association of RILP with its effector RAB34 . Regulates glycolysis by binding to lactate dehydrogenase LDHA, acting as an uncompetitive inhibitor . . |
Accessions | A0A0S2Z5Y7 A0A0S2Z643 J3QQZ7 C9J4C4 ENST00000389169.9 [Q8NFG4-2] ENST00000417064.1 ENST00000285071.9 [Q8NFG4-1] ENST00000461699.1 Q8NFG4 |